|
|
| Line 26: |
Line 26: |
| | <li id="abr">E protein: dengue virus envelope protein</li> | | <li id="abr">E protein: dengue virus envelope protein</li> |
| | <li id="abr">PTRS: peptide of tandem-repeated sequence</li> | | <li id="abr">PTRS: peptide of tandem-repeated sequence</li> |
| | + | <li id="abr">LAE: linear array epitope</li> |
| | + | <li id="abr">CLEC5A: C-type lectin domain, family 5, member A</li> |
| | </ul> | | </ul> |
| | <svg class="section-nav-marker" width="200" height="200"></svg> | | <svg class="section-nav-marker" width="200" height="200"></svg> |
| Line 34: |
Line 36: |
| | <section id="pro"> | | <section id="pro"> |
| | <h2>Prospects</h2> | | <h2>Prospects</h2> |
| − | <p>We believe our the peptide of tandem-repeated sequence (PTRSs), which are produced with linear array epitope (LAE) technique, are able to bind to the envelope protein (E protein) from the dengue virus; meanwhile, PTRSs have a huge potential on many applications. We understand that there are still many works required in order to accomplish these ideas. Here, we list the possible future directions for our project, which will be divided into two parts: environmental detection and treatment.</p> | + | <p>We believe our the peptide of PTRSs, which are produced with LAE technique, are able to bind to the E protein; meanwhile, PTRSs have a huge potential on many applications. We understand that there are still many works required in order to accomplish these ideas. Here, we list the possible future directions for our project, which will be divided into two parts: environmental detection and treatment.</p> |
| | </section> | | </section> |
| | <br> | | <br> |
| Line 48: |
Line 50: |
| | <section id="tre"> | | <section id="tre"> |
| | <h2>Treatment</h2> | | <h2>Treatment</h2> |
| − | <p>Ultimately, we also hope our PTRSs could be involved in the treatment procedure. Ideally, PTRSs are capable to bind to the E protein of the dengue virus. Therefore, they could block the interaction between the C-type lectin domain, family 5, member A (CLEC5A) on a macrophage and the E protein on the virions in the blood. As the result, we could lower the possibility of severe dengue fever.</p> | + | <p>Ultimately, we also hope our PTRSs could be involved in the treatment procedure. Ideally, PTRSs are capable to bind to the E protein of the dengue virus. Therefore, they could block the interaction between CLEC5A on a macrophage and the E protein on the virions in the blood. As the result, we could lower the possibility of severe dengue fever.</p> |
| | <br> | | <br> |
| | <div id="imginfo"> | | <div id="imginfo"> |
